Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ajog.2010.12.060PMID 21310373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting

  2011cited by this paper
• Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach.

  2010cited by this paper
• Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21.

  2010cited by this paper
• Quantification of fetal DNA by use of methylation-based DNA discrimination.

  2010cited by this paper
• Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21.

  2010cited by this paper
• Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing.

  2010cited by this paper
• Detection of increased amounts of cell-free fetal DNA with short PCR amplicons.

  2010cited by this paper
• Births: final data for 2007.

  2010cited by this paper
• Births: final data for 2007.

  2010cited by this paper
• A microarray‐based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease

  2009cited by this paper
• Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease

  2009cited by this paper
• Fetal medicine : basic science and clinical practice

  2008cited by this paper
• Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood

  2008cited by this paper
• SAFE—The Special Non‐invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements

  2008cited by this paper
• Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma.

  2008cited by this paper
• Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma

  2008influential reference
• Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection

  2007cited by this paper
• From micrograms to picograms: quantitative PCR reduces the material demands of high-throughput sequencing

  2007cited by this paper
• Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.

  2006cited by this paper
• Maternal age‐specific fetal loss rates in Down syndrome pregnancies

  2006cited by this paper
• Methods to increase the percentage of free fetal DNA recovered from the maternal circulation.

  2004cited by this paper
• Prenatal screening for open neural tube defects.

  2003cited by this paper
• Revised estimates of the maternal age specific live birth prevalence of Down's syndrome

  2002cited by this paper
• Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.

  1999cited by this paper
• Integrated screening for Down's syndrome.

  1999cited by this paper
• Rapid clearance of fetal DNA from maternal plasma.

  1999cited by this paper
• Two-sided confidence intervals for the single proportion: comparison of seven methods.

  1998cited by this paper
• Presence of fetal DNA in maternal plasma and serum.

  1997cited by this paper
• An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities

  1984cited by this paper
• An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

  1984cited by this paper
• Binomial Confidence Intervals

  1983cited by this paper
• American College of Obstetricians and Gynecologists

  1979cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper

• Non-invasive prenatal testing for the diagnosis of sickle cell disease in high-risk pregnancies: A systematic review and statistical summary of the current literature.

  2025cites this paper
• Medical Students’ Understanding of Down Syndrome in Prenatal Diagnosis: A Cross-sectional Study of Awareness and Knowledge

  2025cites this paper
• Multiple Congenital Anomalies with Breech Presentation: Dilemma in Diagnostic Procedures, Delivery Management, and Counseling in Developing Country

  2025cites this paper
• Bibliometric Analysis of Publications on Prenatal Genetic Screening Using Cell-Free DNA

  2025cites this paper
• Circulating Clues: The Role of Cell-free DNA in Contemporary Prenatal Screening.

  2025cites this paper
• From multi-omics to deep learning: advances in cfDNA-based liquid biopsy for multi-cancer screening

  2025cites this paper
• Prevalence and diversity of retinal disease in adults with Down syndrome

  2024cites this paper
• A capture‐based method of prenatal cell‐free DNA screening for autosomal recessive non‐syndromic hearing loss

  2024cites this paper
• Cell‐free DNA test for fetal chromosomal abnormalities in multiple pregnancies

  2024cites this paper
• Clinical evaluation of noninvasive prenatal testing for sex chromosome aneuploidies in 9,176 Korean pregnant women: a single-center retrospective study

  2024cites this paper
• Physical activity and indices of physical well-being in children and adolescents with trisomy 21

  2024cites this paper
• Trisomy 21 Testing in Second Trimester: Reliability Comparison of Triple and Quadruple Testing in Pakistan

  2023cites this paper
• Reappraisal of evolving methods in non-invasive prenatal screening: Discovery, biology and clinical utility

  2023cites this paper
• Non‐invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China

  2023cites this paper
• Apparent versus effective test performance: The importance of understanding and reviewing performance metrics

  2023cites this paper
• Expanded knowledge of cell-free DNA biology: potential to broaden the clinical utility

  2022cites this paper
• Improving fetal fraction of non-invasive prenatal screening (NIPS) samples collected in EDTA-gel tubes using gel size-selection: a head-to-head comparison of methods.

  2022cites this paper
• Cell-Free Fetal DNA Testing – Oxford Clinical Policy

  2022cites this paper
• Developing computational methods and workflows for targeted and whole-genome sequencing based non-invasive prenatal testing

  2022cites this paper
• Positive predictive value of noninvasive prenatal testing for sex chromosome abnormalities

  2022cites this paper
• Next generation digital PCR: high dynamic range single molecule DNA counting via ultra-partitioning

  2022cites this paper
• Next-Generation Digital Polymerase Chain Reaction: High-Dynamic-Range Single-Molecule DNA Counting via Ultrapartitioning

  2022cites this paper
• Resistance to Change

  2022influential citation
• Noninvasive prenatal screening in southeast China: clinical application and accuracy evaluation

  2022cites this paper
• The performance of grey zone in common foetal aneuploidy screening by semiconductor sequencing

  2022influential citation
• Noninvasive Prenatal Testing and Noninvasive Prenatal Screening

  2022cites this paper
• Prenatal Screening; Cell- Free Fetal DNA Testing

  2022cites this paper
• Critical appraisal of droplet digital polymerase chain reaction application for noninvasive prenatal testing

  2022cites this paper
• Éviter les « pièges » du dépistage prénatal non invasif

  2022cites this paper
• A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X

  2022cites this paper
• Cell-Free Fetal DNA Testing (for Indiana Only) – Community Plan Medical Policy

  2021cites this paper
• Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience

  2021cites this paper
• Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology

  2021cites this paper
• Cell-Free Fetal DNA Testing – Community Plan Medical Policy

  2021cites this paper
• Next Generation Sequencing Based Non-invasive Prenatal Testing (NIPT): First Report From Saudi Arabia

  2021cites this paper
• Effect of preexamination conditions in a centralized-testing model of non-invasive prenatal screening

  2021cites this paper
• The Setup and Application of Reference Material in Sequencing-Based Noninvasive Prenatal Testing

  2021cites this paper
• Steroid profile analysis by liquid chromatography-tandem mass spectrometry in second-trimester pregnant women for trisomy 21 screening.

  2021cites this paper
• Clinical Efficiency of Non-invasive Prenatal Screening for Common Trisomies in Low-Risk and Twin Pregnancies

  2021cites this paper
• A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21

  2020cites this paper
• Prenatal testing

  2020cites this paper
• Cell-Free Fetal DNA Testing

  2020cites this paper
• Pre-analytical Practices in the Molecular Diagnostic Tests, A Concise Review

  2020cites this paper
• Industry, experts and the role of the 'invisible college' in the dissemination of non-invasive prenatal testing in the US.

  2020cites this paper
• Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany

  2020cites this paper
• Cell-Free Fetal DNA Testing – Commercial Medical Policy

  2020cites this paper
• Strategy for Use of Genome-Wide Non-Invasive Prenatal Testing for Rare Autosomal Aneuploidies and Unbalanced Structural Chromosomal Anomalies

  2020cites this paper
• A Review of Gene Sequencing in Infertility

  2020cites this paper
• A novel non‐invasive prenatal sickle cell disease test for all at‐risk pregnancies

  2020cites this paper
• Cell-Free Fetal DNA Testing – UnitedHealthcare West Medical Management Guideline

  2020cites this paper
• Prenatal Testing or Screening?

  2020cites this paper
• Validation of a New Protocol to Collect and Isolate Plasma from Pregnant Women for Noninvasive Prenatal Testing (NIPT).

  2020cites this paper
• The current state of prenatal detection of genetic conditions in congenital heart defects

  2020cites this paper
• Noninvasive Prenatal Testing (NIPT): Current Status

  2020cites this paper
• Describing latent phase duration and associated characteristics among 1281 low-risk women in spontaneous labor.

  2019cites this paper
• Women’s Attitudes Toward Invasive and Noninvasive Testing When Facing a High Risk of Fetal Down Syndrome

  2019cites this paper
• Noninvasive Prenatal Testing for Genetic Diseases

  2019cites this paper
• Genetic Testing

  2019cites this paper
• Prenatal circulating microRNA signatures of foetal Down syndrome

  2019cites this paper
• Prenatal cell‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory

  2019cites this paper
• Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.

  2019cites this paper
• Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?

  2019cites this paper
• Development of an Extraction Protocol for Fetal Sexing from the Fourth Week of Gestation by Real Time PCR

  2019cites this paper
• Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases

  2019cites this paper
• Mothers’ experiences of continuing their pregnancy after prenatally receiving a diagnosis of Down syndrome

  2019cites this paper
• The Effect of In Vitro Hemolysis on Measurement of Cell-Free DNA.

  2019cites this paper
• Detection of chromosomal rearrangements in the short arms of chromosomes 4 and 12 as an example of a whole-genome approach to noninvasive prenatal testing

  2019cites this paper
• Adaptable Model Parameters in Non-Invasive Prenatal Testing Lead to More Stable Predictions

  2019cites this paper
• Circulating DNA, a Potentially Sensitive and Specific Diagnostic Tool for Future Medicine

  2019cites this paper
• Top‐cited articles in the Journal: a bibliometric analysis

  2019cites this paper
• A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.

  2019cites this paper
• An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21

  2019cites this paper
• Noninvasive prenatal testing: the aspects of its introduction into clinical practice

  2019cites this paper
• Single-Cell Omics in Noninvasive Prenatal Testing (NIPT)

  2019cites this paper
• Gebeliğin ilk üç ayındaki kan TSH düzeyi ile Down sendromu tarama testleri arasındaki ilişki

  2018cites this paper
• Sequencing Cell-Free DNA in the Maternal Circulation to Screen for Down Syndrome, Other Common Trisomies, and Selected Genetic Disorders

  2018cites this paper
• Diagnostic prénatal par prélèvement de sang maternel

  2018cites this paper
• Screening chromosomal anomalies in early pregnancy: When and why

  2018cites this paper
• The applications of massive parallel sequencing (next-generation sequencing) in research and molecular diagnosis of human genetic diseases

  2018cites this paper
• Noninvasive Approaches to Prenatal Diagnosis: Historical Perspective and Future Directions.

  2018cites this paper
• Bi-stream CNN Down Syndrome screening model based on genotyping array

  2018cites this paper
• Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing

  2018cites this paper
• A novel approach to stabilize fetal cell-free DNA fraction in maternal blood samples for extended period of time

  2018cites this paper
• Translational research advances a new era of prenatal diagnosis and newborn screening

  2018cites this paper
• Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients

  2018cites this paper
• The epidemic of abnormal copy number variant cases missed because of reliance upon noninvasive prenatal screening

  2018cites this paper
• Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy

  2018cites this paper
• The price of abandoning diagnostic testing for cell‐free fetal DNA screening

  2018cites this paper
• Prognostic value of the aortic isthmus Doppler assessment on late onset fetal growth restriction

  2018cites this paper
• Profile of women choosing the Harmony® Prenatal Test

  2018cites this paper
• Biological explanations for discordant noninvasive prenatal test results: Preliminary data and lessons learned

  2018cites this paper
• Highly sensitive and rapid isolation of fetal nucleated red blood cells with microbead-based selective sedimentation for non-invasive prenatal diagnostics

  2018cites this paper
• Circulating cell-free DNA for non-invasive cancer management.

  2018cites this paper
• The value of cell‐free DNA for molecular pathology

  2018cites this paper
• Phylogeny, Ancestral Genome, And Disease Diagnoses Models Constructions Using Biological Data

  2018cites this paper
• Bioinformatic Approaches to Detecting Copy Number Variation in Next Generation Sequencing Data for Clinical Diagnostics

  2018cites this paper
• Maternal plasma metabolic fingerprint indicative for fetal Down syndrome

  2018cites this paper
• Diagnóstico prenatal mediante muestra de sangre materna

  2018cites this paper
• Development of a comprehensive noninvasive prenatal test

  2018cites this paper
• Isolation and whole genome sequencing of fetal cells from maternal blood towards the ultimate non‐invasive prenatal testing

  2017cites this paper